Cargando…
The In Vivo and In Vitro Assessment of Pyocins in Treating Pseudomonas aeruginosa Infections
Pseudomonas aeruginosa can cause several life-threatening infections among immunocompromised patients (e.g., cystic fibrosis) due to its ability to adapt and develop resistance to several antibiotics. In recent years, P. aeruginosa infections has become difficult to treat using conventional antibiot...
Autores principales: | Alqahtani, Abdulaziz, Kopel, Jonathan, Hamood, Abdul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598984/ https://www.ncbi.nlm.nih.gov/pubmed/36290026 http://dx.doi.org/10.3390/antibiotics11101366 |
Ejemplares similares
-
Plant-expressed pyocins for control of Pseudomonas aeruginosa
por: Paškevičius, Šarūnas, et al.
Publicado: (2017) -
Anti-Pseudomonas aeruginosa Vaccines and Therapies: An Assessment of Clinical Trials
por: Elmassry, Moamen M., et al.
Publicado: (2023) -
Pyocin efficacy in a murine model of Pseudomonas aeruginosa sepsis
por: Six, Anne, et al.
Publicado: (2021) -
O serotype-independent susceptibility of Pseudomonas aeruginosa to lectin-like pyocins
por: Ghequire, Maarten G K, et al.
Publicado: (2014) -
Spatial structure maintains diversity of pyocin inhibition in household Pseudomonas aeruginosa
por: Mojesky, Aubrey A., et al.
Publicado: (2020)